Showing 91 - 100 of 270
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical stage targeting 11 emerging infectious diseases. We calibrate the simulation parameters with input from domain experts in mRNA technology and an extensive literature review. We find...
Persistent link: https://www.econbiz.de/10013334345
Persistent link: https://www.econbiz.de/10014456944
Persistent link: https://www.econbiz.de/10014325341
Persistent link: https://www.econbiz.de/10014307822
Persistent link: https://www.econbiz.de/10014308460
Persistent link: https://www.econbiz.de/10014308519
Persistent link: https://www.econbiz.de/10014290784
Persistent link: https://www.econbiz.de/10014292044
Persistent link: https://www.econbiz.de/10014294022
Persistent link: https://www.econbiz.de/10014295465